Oncological results of 117 consecutive radical prostatectomies;Résultats carcinologiques de 117 prostatectomies radicales consécutives

Progres en Urologie

Volumn 15, Issue 1, 2005, Pages 30-35

  Turpin Wendling, François Nicolas ^a   Sahnoun, Ahmed ^a   Pariente, Antoine ^b   Pariente, Jean Louis ^a   Ferriere, Jean Marie ^a   Le Guillou, Michel ^a  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Prognostic factors; Prostate cancer; Prostatectomy

Indexed keywords

HORMONE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; GLEASON SCORE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MULTIVARIATE ANALYSIS; PERINEUM; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL RATE; TUMOR BIOPSY;

AGED; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 16244408937     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. BADER P., BURKHARD F.C., MARKWALDER R., STUDER E.: Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J. Urol. 2002; 168: 514-518.
2. BURKHARD F.C., BADER P., SCHNEIDER E., MARKWALDER R., STUDER E. : Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. Eur. Urol., 2002; 42: 84-98.
3. CATALONA W.J., SMITH DS : Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: Intermediate-term results. J. Urol., 1998; 160: 2428-2434.
4. CLOBES H., FOSSA S.D., WAEHRE H., BERNER A.: The immunohistochemical assesment of occult regional lymph node metastases in patients with T3N0M0 postate cancer before definitive radiotherapy. Brit. J. Urol., 2000; 85: 270-275.
5. GERBER GS., THISTED R.A., CHODAK G.W., SCHRODER F.H., FROHMULLER H.G., SCARDINO P.T., PAULSON D.F., MIDDLETON A.W. Jr., RUKSTALLS D.B., SMITH J.A. Jr., OHORL M., THELSS M., SCHELLHAMMER P.F. Results of radical prostatectomy in men with clinically localized prostate cancer, multi institutional pooled analysis. JAMA, 1996; 8: 615-619
6. GLASDONE C., JOHNSON J.W., TENNEY D.M., JOHNSON D.,: Pelvic lymphadenectomy for staging clinically localized prostate cancer. Urology, 1990; 35: 476-481
7. GOMELLA L.G., WHITE J.L., McCUE P.A.: Screeming for occult micrometastasis in in localized carcinoma of the prostate. J.Urol. 1993; 149: 776-778
8. HAN M., PARTIN A., POUND CR., EPSTEIN JI., WALSH PC.: Long -Term Biochemical disease-free and cancer specific survival following anatomic radical retropubic prostatectomy. Urol. Clin. North Am., 2001 ; 3: 555-565.
9. HEIDENRICH A., VARGA Z., VON KNOBLOCH R.: Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy:high incidence of lymph node metastasis. J.Urol., 2002; 167:1681-1686.
10. MALAVAUD B., GAME X., VILLERS A.: Récidive biologique secondaire après prostatectomie radicale : analyse multivariée des facteurs pronostiques cliniques, biologiques et histologiques. Prog. Urol . , 2001 ;11 : 277-282.
11. MOUL J.W., LEWIS D.J., ROSS A.A.: Immunohistologic detection of prostate cancer pelvic lymph node micrometastases: Correlation to pre operative serum PSA. Urology, 1994; 43: 68-73.
12. NOGUSHI M., STAMEY TA., McNEAL JE.: Prognostic factors for multifocal cancer in radical prostatectomy specimen : lack of significance of secondary cancer. J. Urol., 2000; 170, 8: 459-463.
13. SCARDINO P.T. HULL G.W., RABBANI F., ABBAS F.: Cancer control with radical prostatectomy alone in 1000 consecutive patients. J. Urol., 2002 ;167: 528-534.
14. STAMEY T.A, YEMOTO C.M., Mc NEAL J.E.: Prostate Cancer is highly predictable : a prognostic equation based on all morphological variables in radical prostatectomy specimens. J. Urol., 2000; 163: 1155-1160.
15. TOSTAIN J., VERSINI P., LEGON P.: Effets anatomo-cliniques du traitement hormonal néoadjuvant avant prostatectomie. Prog.Urol., 1997 ; 7 : 570-578.
16. WIEDER J.A., SOLOWAY MA.:Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J. Urol. 1998; 160 : 299-315.
17. WINKLER M.H., KHAN F.A., BLAKE-JAMES B.: Case selection for radical prostatectomy in the UK. Eur.Urol., 2004; 46: 444-450
18. ZINCKE H., WARD J.F., BLUTE M.L., SLEZAK J.: The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J. Urol. 2003; 170: 1872-1876.
19. ZINCKE H., AMLING C.L., BERGSTRALH E.J.: Defining prostate specific antigen progression after prostatectomy: what is the most appropriate cut point ? J. Urol., 2001; 165: 1146-1151.